InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | 2026-03-12 | Wilson John J. Addington | CHIEF OPERATING OFFICER | Sale | 9,603 | $4.32 | $41K | 316.8K | View ↗ | |
| 2026-03-11 | 2026-03-12 | WIRTJES SEAN M | CHIEF FINANCIAL OFFICER | Sale | 7,480 | $4.32 | $32K | 556.2K | View ↗ | |
| 2026-03-10 | 2026-03-12 | Spignesi Robert G. Jr. | Director & PRESIDENT AND CEO | Sale | 17.9K | $4.11 | $74K | 1.17M | View ↗ | |
| 2026-02-20 | 2026-02-20 | Wilson John J. Addington | CHIEF OPERATING OFFICER | Sale | 5,403 | $3.92 | $21K | 326.4K | View ↗ | |
| 2026-02-20 | 2026-02-20 | WIRTJES SEAN M | CHIEF FINANCIAL OFFICER | Sale | 17.3K | $3.92 | $68K | 563.7K | View ↗ |
| Agency | Amount |
|---|---|
| Department of Health and Human Services | $3.52B |
From USASpending.gov. Matched by company name keyword.
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total revenue | $10.2M+9.0% | $9.3M+20.9% | $7.7M | $0-100.0% | $1.6M |
| Research and development | $13.6M-6.8% | $14.6M+13.9% | $12.8M-0.4% | $12.9M+31.5% | $9.8M |
| Sales and marketing | $12.1M-8.9% | $13.3M-0.4% | $13.3M-11.2% | $15.0M+26.9% | $11.8M |
| General and administrative | $22.8M+3.7% | $21.9M-12.0% | $24.9M-7.0% | $26.8M+49.9% | $17.9M |
| Total costs and operating expenses | $81.0M+3.9% | $78.0M-1.4% | $79.1M-1.6% | $80.4M+14.0% | $70.5M |
| Loss from operations | -$47.4M+5.1% | -$49.9M+11.7% | -$56.6M+10.5% | -$63.2M-33.8% | -$47.2M |
| Interest income | $1.5M-52.9% | $3.2M | — | — | — |
| Interest expense | -$1.1M-2625.0% | -$40K | — | — | — |
| Other expense, net | -$110K+1.8% | -$112K-34.9% | -$83K-240.7% | $59K+106.9% | -$850K |
| Total other income, net | $309K-89.9% | $3.1M-26.0% | $4.1M+124.7% | $1.8M+107.0% | -$26.2M |
| Loss before income taxes | -$47.1M-0.5% | -$46.9M+10.6% | -$52.4M+14.6% | -$61.4M+16.4% | -$73.4M |
| Income tax expense | $40K+81.8% | $22K-29.0% | $31K+105.4% | -$576K-733.0% | $91K |
| Net loss | -$47.1M-0.5% | -$46.9M+10.6% | -$52.5M+13.7% | -$60.8M+17.3% | -$73.5M |
| Net loss per share — basic (in dollars per share) | -$1K+2.8% | -$1K+11.5% | -$1K+14.7% | -$1K+63.7% | -$4K |
| Net loss per share — diluted (in dollars per share) | -$1K+2.8% | -$1K+11.5% | -$1K+14.7% | -$1K+63.7% | -$4K |
| Weighted average common shares outstanding - basic (in shares) | $44.68B+2.5% | $43.58B+1.3% | $43.02B+1.3% | $42.45B+114.6% | $19.78B |
| Weighted average common shares outstanding - diluted (in shares) | $44.68B+2.5% | $43.58B+1.3% | $43.02B+1.3% | $42.45B+114.6% | $19.78B |
| Product | |||||
| Cost of revenue | $6.6M-7.8% | $7.1M-10.4% | $7.9M | $0-100.0% | $1.6M |
| Service | |||||
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Rapid Micro Biosystems prices $9.8M capital raise with up to $21.7M in additional warrant potential
Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering
Rapid Micro Biosystems Inc (RPID) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...
Rapid Micro Biosystems Q1 Earnings Call Highlights